User menu

A multicenter Phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy.

Bibliographic reference Vergote, Ignace ; Humblet, Yves ; Van Cutsem, Emmanuel ; Van Belle, S. ; Kerger, Joseph ; et. al. A multicenter Phase II trial of gefitinib 500 mg/day in 192 patients with advanced epidermal growth factor receptor-positive solid tumors who had failed previous chemotherapy..In: EJC - Supplements, Vol. 3, no. 2, p. 423-423 (2005)
Permanent URL http://hdl.handle.net/2078.1/59603